Nho Osaka National Hospital

Osakashi, Osaka 540-0006

0 studies enrolling now · 2 studies all time

What they study most

Gastric, or Gastroesophageal Junction Adenocarcinoma, Hepatocellular Carcinoma (HCC)

Studies at this site

• A Study of Tislelizumab Versus Sorafenib in Participants With Unresectable Hepatocellular Carcinoma (HCC) — Completed
• Tislelizumab in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Gastric, or Gastroesophageal Junction Carcinoma — Completed